Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced photoinitiator synthesis patent CN106866500A offers high purity and industrial scalability for electronic chemical manufacturing supply chains.
Novel patent CN104529734A details efficient Fingolimod Hydrochloride synthesis offering supply chain stability and cost reduction for pharmaceutical manufacturing partners.
Novel iodine-catalyzed route for Brexpiprazole intermediate using low-cost thiophene. Reduces palladium dependency and enhances supply chain stability.
Patent CN108676048B reveals a novel adenosine-based route for cordycepin. Achieve high purity and cost reduction in nucleoside manufacturing with scalable catalytic transfer hydrogenation.
Advanced synthesis of MMP inhibitors via novel Friedel-Crafts and Sonogashira coupling. Cost-effective manufacturing for high-purity pharmaceutical intermediates.
Novel patent CN107987082A details improved Larotrectinib synthesis with lower temperatures and higher purity, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Novel synthesis route for cefcapene diisopropylamine salt ensures high purity and cost efficiency for global antibiotic supply chains.
Patent CN113248356A reveals a scalable two-step route for 4-hydroxy-1-indanone, offering cost reduction in pharmaceutical intermediate manufacturing via mild acid catalysis.
Novel synthetic route for Alectinib intermediate offering high yield and cost efficiency. Ideal for pharmaceutical intermediate supply chain optimization.
Novel patent CN118063427A reveals efficient synthesis route for herbicide intermediates. Offers significant cost reduction and supply chain reliability for global agrochemical manufacturers.
Patent CN1871204A reveals a superior method for synthesizing 2-dihaloacyl-3-amino-acrylic acid esters, offering cost reduction in fungicide manufacturing and enhanced supply chain reliability.
Patent CN102093247B reveals a novel silver-mediated acylation route for Tolvaptan intermediates, offering safer conditions and high purity compared to traditional palladium methods.
Patent CN1422261A details a novel Lewis acid-catalyzed process for 1,3,4-oxadiazole derivatives, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN1628087A reveals a novel onium salt catalyzed route for alkenone synthesis, offering superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Discover a novel, non-Grignard synthesis for 1-cyclopropyl-2-(2-fluorophenyl) ethyl ketone. Enhanced safety, mild conditions, and scalable manufacturing for antithrombotic APIs.
Patent CN111704559A reveals a safer, high-yield route for Ozanimod intermediates, eliminating toxic cyanides and reducing thermal stress in API manufacturing.
Novel Lewis acid catalyzed method ensures 99% purity for 2-hydroxybenzophenone. Reduces impurities and scales efficiently for global pharmaceutical supply chains.
Patent CN113461502B enables high-purity 2-hydroxybenzophenone synthesis. Streamlined Lewis acid catalysis offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104402786A reveals a one-pot synthesis for DBD rubber peptizers offering reduced waste and improved yield for global polymer additive supply chains.
Patent CN102388017B details an anhydrous synthesis route for azelaic acid derivatives, offering improved purity and yield for cosmetic and pharmaceutical intermediate manufacturing.